Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rexall Sundown

This article was originally published in The Tan Sheet

Executive Summary

President Damon DeSantis assumes additional post of CEO with Chris Nast's appointment to vice chairman. DeSantis joined Rexall in 1983 and was named president in early 1998. Nast joined the company in 1995 as president and chief operating officer and assumed the role of CEO in 1997. Separately, the firm announces exclusive U.S. distribution rights to Italian firm Medestea International's Cellasene dietary supplement, which claims to "Help eliminate cellulite." The softgel product contains ginkgo biloba to help increase circulation and grape seed extract, an antioxidant. Launching in food, drug and mass market outlets nationwide in March, a 10-day supply retails for approximately $40. Rexall also has rights for Cellasene in several foreign markets

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel